HES1 and acute myeloid leukemia: Differently from hBM-MSCs, which expressed low to undetectable levels of the Notch target gene Hes1, hBM-MSCs*showed higher level of Hes1 protein, thus suggesting that active Notch signalling is operational in bone marrow microenvironment of AML patients (Figure 1C).